Bridging Health Gaps: Landcent and EASE Partner for Affordable, High-Quality, Locally Manufactured, Diagnostics in Africa

Diagnostics play a critical role in accurately identifying poverty-related diseases, guiding treatment, monitoring progress, and assessing responses to therapy. Yet, access to high-quality, affordable, and user-friendly diagnostic tools remains a significant challenge in resource-limited areas across sub-Saharan Africa.

Building on our product development expertise in malaria prevention and deep roots in Global Health, Landcent is now integrating diagnostics into our approach to address the full spectrum of care—prevention, diagnosis, and treatment. This holistic strategy will strengthen our impact and support efforts toward disease elimination in underserved regions.

Introducing EASE-Medtrend

EASE-Medtrend is a multifaceted biotech company with activities spanning research and development, design, manufacture and sales and marketing of tests in the clinical, veterinary, food safety, environment and water fields. As a comprehensive solution provider to the diagnostic industry, EASE-Medtrend Biotech Ltd., focuses on test designs that prioritize ease of use, affordability, and accuracy. The company's expertise extends to technology transfer, manufacturing, and marketing, with innovative applications such as mobile phone-based diagnostics utilizing biosensors, image analysis, spectrophotometry, and microscopy. EASE-Medtrend is also committed to establishing local manufacturing facilities globally, alongside developing robust supply chain ecosystems in target countries.

A Partnership for Impact

Landcent and EASE have joined forces to bring affordable, high-quality and innovative diagnostic solutions to sub-Saharan Africa. This partnership aims to address critical healthcare challenges by introducing locally manufactured diagnostics that are tailored to address the challenges of underserved regions.

“I believe the two essential ingredients to success in a mission is the capacity and the will to do so. I believe our partnership creates technical and strategic capacities beyond our individual organizations; but even more important is our alliance strengthens our will and unwavering commitment to serve,“ said Peter Chun, CEO, EASE-Medtrend Biotech.

"By combining EASE's strong expertise in developing diagnostics tests with Landcent's commitment to deliver affordable healthcare solutions, this partnership represents a significant step toward addressing health in equities in Africa. Together, we aim to ensure that no community is left behind in the fight against poverty-related diseases," said Arun Prabhu Stanley, CEO and co-founder of Landcent Europe.

Through this collaboration, Landcent and EASE reaffirm their shared commitment to making a lasting impact on Global Health.